ctrl K

Watchlist Price Alert

Pasithea Therapeutics Cor... (KTTAW)

NASDAQ: KTTAW · Real-Time Price · USD

0.02

0.00 (17.65%)

At close: May 14, 2025, 3:59 PM

Pasithea Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	n/a	n/a	486.56K	15.06K	n/a
Cost of Revenue	n/a	648.45K	113.19K	17.27K	n/a
Gross Profit	n/a	-648.45K	373.36K	-2.21K	n/a
Operating Income	-14.25B	-15.98M	-14.82M	-4.51M	-40.98K
Interest Income	n/a	n/a	102.00	508.00	n/a
Pretax Income	-13.9B	-15.51M	-13.94M	-2.17M	-40.98K
Net Income	-13.9B	-15.96M	-13.06M	-2.17M	-40.98K
Selling & General & Admin	7.05B	7.88M	12.52M	4.51M	40.98K
Research & Development	7.2B	8.1M	2.67M	n/a	n/a
Other Expenses	n/a	n/a	44.72K	n/a	n/a
Operating Expenses	13.6M	15.98M	15.19M	4.51M	40.98K
Interest Expense	n/a	n/a	102.00	508.00	n/a
Selling & Marketing Expenses	n/a	-7.87B	2.6M	n/a	n/a
Cost & Expenses	n/a	15.98M	15.3M	4.52M	40.98K
Income Tax Expense	n/a	n/a	-879.97K	508.00	-61.48K
Shares Outstanding (Basic)	1.1M	1.26M	1.26M	1.15M	688.92K
Shares Outstanding (Diluted)	1.1M	1.23M	1.26M	1.15M	688.92K
EPS (Basic)	-12.69K	-12.65	-10.34	-1.89	-0.06
EPS (Diluted)	-12.69K	-13.01	-10.34	-1.89	-0.06
EBITDA	-13.26M	-15.33M	-12.58M	-4.51M	n/a
EBIT	n/a	-15.98M	-12.59M	-4.51M	-61.48K
Depreciation & Amortization	n/a	648.45K	5.09K	1.38K	61.48K